Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

PubWeight™: 8.29‹?› | Rank: Top 0.1%

🔗 View Article (PMID 12551853)

Published in Circulation on January 28, 2003

Authors

Paul M Ridker1

Author Affiliations

1: Center for Cardiovascular Disease Prevention and the Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02215, USA. pridker@partners.org

Associated clinical trials:

Thrombotic, Inflammatory & Gene Markers of CVD in Women | NCT00006539

Innovative Strategies For Risk Reduction Following CABG | NCT00462436

Sea Swimming for Treatment of Depression and Anxiety | NCT04528485

Articles citing this

(truncated to the top 100)

Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull (2011) 4.27

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09

C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax (2005) 2.72

Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum (2012) 2.09

Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax (2005) 2.03

Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol (2013) 1.93

Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics (2010) 1.90

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials (2007) 1.86

C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol (2004) 1.81

Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes. J Am Coll Cardiol (2013) 1.77

Low birth weight and markers of inflammation and endothelial activation in adulthood: the ARIC study. Int J Cardiol (2008) 1.73

Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease. Circulation (2015) 1.69

Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biol (2013) 1.63

Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation (2010) 1.60

Gut microbiota and inflammation. Nutrients (2011) 1.60

The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care (2010) 1.58

Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48

Within-person variability in high-sensitivity C-reactive protein. Arch Intern Med (2012) 1.48

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis (2007) 1.46

Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol (2016) 1.46

Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 1.42

Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology. Int J Cardiovasc Imaging (2005) 1.42

Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol (2010) 1.41

The association between plasma 25-hydroxyvitamin D3 concentrations, C-reactive protein levels, and coronary artery atherosclerosis in postmenopausal monkeys. Menopause (2012) 1.40

Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J Gerontol A Biol Sci Med Sci (2006) 1.40

The Impact of Educational Attainment on Observed Race/Ethnic Disparities in Inflammatory Risk in the 2001-2008 National Health and Nutrition Examination Survey. Int J Environ Res Public Health (2015) 1.39

Dyslipidemic drugs in metabolic syndrome. Indian J Endocrinol Metab (2013) 1.39

Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38

Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol (2009) 1.38

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer (2010) 1.31

Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci (2009) 1.30

The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci (2012) 1.29

Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci U S A (2005) 1.27

Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis (2009) 1.26

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol (2007) 1.25

Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med (2006) 1.24

Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med (2010) 1.23

Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag (2006) 1.23

Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J (2011) 1.23

Elevated serum transferrin saturation and mortality. Ann Fam Med (2004) 1.22

Biomarkers in acute myocardial infarction. BMC Med (2010) 1.22

Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.21

The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21

Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PLoS One (2012) 1.20

The effect of a worksite based walking programme on cardiovascular risk in previously sedentary civil servants [NCT00284479]. BMC Public Health (2006) 1.17

Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond) (2013) 1.15

Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol (2007) 1.15

Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology (2007) 1.13

Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol (2005) 1.10

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail (2007) 1.10

Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09

Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats. Clin Chem (2008) 1.09

Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart (2004) 1.08

Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol (2010) 1.08

Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One (2013) 1.07

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J (2004) 1.07

Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep (2012) 1.06

CRP and the risk of atherosclerotic events. Semin Immunopathol (2009) 1.06

DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr (2009) 1.06

IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet (2008) 1.06

Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. J Clin Oncol (2012) 1.05

Sedentary time and markers of chronic low-grade inflammation in a high risk population. PLoS One (2013) 1.05

Roles of IL-6-gp130 Signaling in Vascular Inflammation. Curr Cardiol Rev (2008) 1.04

Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study. Diabetes Care (2013) 1.02

Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation. Cytokine (2011) 1.02

Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav Immun (2011) 1.02

Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr (2011) 1.01

Racial differences in C-reactive protein levels during normal pregnancy. Am J Obstet Gynecol (2008) 1.01

Association between dietary pattern and serum C-reactive protein in Japanese men and women. J Epidemiol (2011) 1.01

Acute-phase proteins: As diagnostic tool. J Pharm Bioallied Sci (2011) 1.00

Obstructive Sleep Apnoea: From pathogenesis to treatment: Current controversies and future directions. Respirology (2010) 1.00

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol (2010) 1.00

Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health (2012) 1.00

Absolute quantification of C-reactive protein in human plasma derived from patients with epithelial ovarian cancer utilizing protein cleavage isotope dilution mass spectrometry. J Proteome Res (2009) 0.99

Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS One (2011) 0.99

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study. BMC Infect Dis (2013) 0.99

The Association between Oxidative Stress and Metabolic Syndrome in Adults. Korean J Fam Med (2013) 0.98

Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol (2007) 0.98

The impact of bariatric surgery on nutritional status of patients. Wideochir Inne Tech Maloinwazyjne (2015) 0.98

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis (2008) 0.98

The Effects of Panax Ginseng on Lipid Profile, Pro-oxidant: Antioxidant Status and High-sensitivity C Reactive Protein Levels in Hyperlipidemic Patients in Iran. Int J Prev Med (2013) 0.97

Assessment of dietary habits, nutritional status and blood biochemical parameters in patients prepared for bariatric surgery: a preliminary study. Wideochir Inne Tech Maloinwazyjne (2012) 0.97

Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease. Diabetes Metab J (2011) 0.96

CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res (2011) 0.95

High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J Clin Endocrinol Metab (2008) 0.94

Periodontitis and plasma C-reactive protein during pregnancy. J Periodontol (2006) 0.94

C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol (2008) 0.94

INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units. Multidiscip Respir Med (2013) 0.93

Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis (2008) 0.93

Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ (2006) 0.93

Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One (2012) 0.93

Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol (2012) 0.93

Fast-track surgery improves postoperative clinical recovery and reduces postoperative insulin resistance after esophagectomy for esophageal cancer. Support Care Cancer (2013) 0.93

Physical activity, health benefits, and mortality risk. ISRN Cardiol (2012) 0.93